aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.794
+0.003 (0.34%)
At close: Apr 28, 2026, 4:00 PM EDT
0.794
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
aTyr Pharma Employees
As of December 31, 2025, aTyr Pharma had 60 total employees, including 58 full-time and 2 part-time employees. The number of employees increased by 1 or 1.69% compared to the previous year.
Employees
60
Change (1Y)
1
Growth (1Y)
1.69%
Revenue / Employee
$3,167
Profits / Employee
-$1,235,300
Market Cap
77.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| Pelthos Therapeutics | 92 |
| XBiotech | 85 |
| ImmuCell | 73 |
| Seres Therapeutics | 66 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Filana Therapeutics | 20 |
ATYR News
- 5 days ago - Ethos Collaborates with Liberty Mutual to Deliver a Modern, Digital-First Life Insurance Experience - GlobeNewsWire
- 26 days ago - Ethos to Announce First Quarter 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 5 weeks ago - Ethos and Banner Life Expand Offering to Bring Final Expense Coverage to More Families - GlobeNewsWire
- 6 weeks ago - aTyr Pharma Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - aTyr Pharma Announces Fourth Quarter and Full Year 2025 Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - Ethos to Participate in The Citizens Technology Conference - GlobeNewsWire
- 2 months ago - Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire